ArticleJournal of clinical medicine2026

A Pilot Study of the Effectiveness and Safety of Subcutaneous Infliximab in Chronic Inflammatory Pouch Conditions: The St. Mark's Experience.

Itai Ghersin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.